Fixed Price IPO | ₹20 Cr | Listed at NSE SME | Fri, Sep 29, 2017 - Wed, Oct 4, 2017
Beta Drugs IPO is a fixed price issue of ₹19.52 crores. The issue is entirely a fresh issue of 0.23 crore shares of ₹19.52 crore.
Beta Drugs IPO bidding started from Sep 29, 2017 and ended on Oct 4, 2017. The shares got listed on NSE SME on Oct 12, 2017.
Beta Drugs IPO price is ₹85 per share. The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹1,36,000 (1600 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (3,200 shares), amounting to ₹2,72,000.
Pantomath Capital Advisors Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Pantomath Stock Brokers Pvt.Ltd..
Refer to Beta Drugs IPO RHP for detailed Information.
IPO Open
Fri, Sep 29, 2017
IPO Close
Wed, Oct 4, 2017
Issue Price
₹85 per share
Market Cap (Pre-IPO)
₹73.52 Cr
| IPO Date | 29 Sep to 4 Oct, 2017 |
| Listed on | Thu, Oct 12, 2017 |
| Face Value | ₹10 per share |
| Issue Price | ₹85 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Total Issue Size | 22,96,000 shares (agg. up to ₹20 Cr) |
| Reserved for Market Maker | 1,29,600 shares Pantomath Stock Brokers Pvt.Ltd. (agg. up to ₹1 Cr) |
| Fresh Issue (Ex Market Maker) | 21,66,400 shares (agg. up to ₹18 Cr) |
| Net Offered to Public | 21,66,400 shares (agg. up to ₹18 Cr) |
| Share Holding Pre Issue | 63,35,500 shares |
| Share Holding Post Issue | 86,49,500 shares |
| NSE Symbol | BETA |
| ISIN | INE351Y01019 |
Beta Drugs IPO comprises a total issue size of 22,96,000 shares. The net offer to the public is 21,66,400 shares, after excluding 1,29,600 shares allotted on a firm basis. Of the Net offer 10,83,200 (50.00%) allocated to NII 10,83,200 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 10,83,200 | 50.00% | 47.18% |
| Retail Shares Offered | 10,83,200 | 50.00% | 47.18% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,29,600 | 5.64% | |
| Total Shares Offered | 22,96,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,600 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,36,000 |
| Retail (Max) | 1 | 1,600 | ₹1,36,000 |
| HNI (Min) | 2 | 3,200 | ₹2,72,000 |
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.
Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.
Company Strengths:
1. Focus on oncology segment. Manufacture over 50 products in this segment.
2. 18 product registrations in various countries. Company is in-process of making additional 12 applications for product registration in various countries.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of new plant and machinery and upgradtion of the existing plant and machinery | 7.42 |
| 2 | Civil Construction work at existing manufacturing unit. | 1.28 |
| 3 | To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme | 0.79 |
| 4 | Working Capital | 2.95 |
| 5 | General Corporate Purpose | 4.10 |
The Beta Drugs IPO is subscribed [.] times on October 4, 2017 5:00:00 PM (Day 3). The public issue subscribed [.] times in the retail category, [.] times in the QIB category, and [.] times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Payment to Merchant Banker including expenses towards printing, advertising, and payment to other intermediaries such as Registrars, Bankers etc. | 2.69 |
| 2 | Regulatory fees | 0.15 |
| 3 | Marketing and Other Expenses | 0.15 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹85.00 |
| Open | ₹102.00 |
| Low | ₹92.00 |
| High | ₹102.00 |
| Last Trade | ₹101.95 |
Lead Manager Reports
Beta Drugs IPO is a SME IPO of 22,96,000 equity shares of the face value of ₹10 aggregating up to ₹20 Crores. The issue is priced at ₹85 per share. The minimum order quantity is 1600.
The IPO opens on Fri, Sep 29, 2017, and closes on Wed, Oct 4, 2017.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Beta Drugs IPO using UPI as a payment gateway. Zerodha customers can apply in Beta Drugs IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Beta Drugs IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Beta Drugs IPO opens on Fri, Sep 29, 2017 and closes on Wed, Oct 4, 2017.
Beta Drugs IPO lot size is 1600, and the minimum amount required for application is ₹1,36,000.
You can apply in Beta Drugs IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Beta Drugs IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Beta Drugs IPO allotment status.
The Beta Drugs IPO listing date is on Thu, Oct 12, 2017.
